Jul 30 |
EYE vs. PODD: Which Stock Is the Better Value Option?
|
Jul 26 |
Are Ozempic Jitters to Blame for DexCom's Stock-Price Plunge?
|
Jul 26 |
Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today?
|
Jul 26 |
Insulet's prelim Q2 revenue tops estimates
|
Jul 26 |
Insulet Reports Preliminary Second Quarter 2024 Revenue Results
|
Jul 18 |
All You Need to Know About Insulet (PODD) Rating Upgrade to Strong Buy
|
Jul 12 |
Should You Be Impressed By Insulet Corporation's (NASDAQ:PODD) ROE?
|
Jul 8 |
Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024
|
Jul 5 |
(PODD) - Analyzing Insulet's Short Interest
|
Jun 25 |
Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2
|